Primary Site >> Colorectal Cancer
Gene >> ENG
| 1. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13. | ||||||||||
| Title: | Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. | ||||||||||
| Author: | Chang, Y S|di Tomaso, E|McDonald, D M|Jones, R|Jain, R K|Munn, L L | ||||||||||
| PMID: | 11121063 | ||||||||||
| 2. | |||||||||||
| Journal: | Clin Cancer Res. 2001 Mar;7(3):524-32. | ||||||||||
| Title: | Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. | ||||||||||
| Author: | Takahashi, N|Kawanishi-Tabata, R|Haba, A|Tabata, M|Haruta, Y|Tsai, H|Seon, B K | ||||||||||
| PMID: | 11297243 | ||||||||||
| 3. | |||||||||||
| Journal: | Anticancer Res. 2001 Sep-Oct;21(5):3175-84. | ||||||||||
| Title: | Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts. | ||||||||||
| Author: | Teicher, B A|Menon, K|Alvarez, E|Galbreath, E|Shih, C|Faul, M M | ||||||||||
| PMID: | 11848470 | ||||||||||
| 4. | |||||||||||
| Journal: | FASEB J. 2003 Jun;17(9):984-92. | ||||||||||
| Title: | CD105 is important for angiogenesis: evidence and potential applications. | ||||||||||
| Author: | Duff, Sarah E|Li, Chenggang|Garland, John M|Kumar, Shant | ||||||||||
| PMID: | 12773481 | ||||||||||
| 5. | |||||||||||
| Journal: | Mod Pathol. 2004 Feb;17(2):197-203. | ||||||||||
| Title: | Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. | ||||||||||
| Author: | Saad, Reda S|Liu, Yulin L|Nathan, Girija|Celebrezze, James|Medich, David|Silverman, Jan F | ||||||||||
| PMID: | 14657950 | ||||||||||
| 6. | |||||||||||
| Journal: | Virchows Arch. 2006 Feb;448(2):127-34. Epub 2005 Sep 22. | ||||||||||
| Title: | Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. | ||||||||||
| Author: | Minhajat, Rahmawati|Mori, Daisuke|Yamasaki, Fumio|Sugita, Yasuo|Satoh, Toshimi|Tokunaga, Osamu | ||||||||||
| PMID: | 16177881 | ||||||||||
| 7. | |||||||||||
| Journal: | Postepy Hig Med Dosw (Online). 2006;60:453-70. | ||||||||||
| Title: | [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer]. | ||||||||||
| Author: | Widel, Maciej S|Widel, Maria | ||||||||||
| PMID: | 17013365 | ||||||||||
| 8. | |||||||||||
| Journal: | Int J Oncol. 2006 Nov;29(5):1087-94. | ||||||||||
| Title: | Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: differences in growth rate and therapeutic response between tumors growing at different sites. | ||||||||||
| Author: | Tsujie, Masanori|Uneda, Shima|Tsai, Hilda|Seon, Ben K | ||||||||||
| PMID: | 17016638 | ||||||||||
| 9. | |||||||||||
| Journal: | Pathol Int. 2006 Dec;56(12):717-23. | ||||||||||
| Title: | Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. | ||||||||||
| Author: | Minhajat, Rahmawati|Mori, Daisuke|Yamasaki, Fumio|Sugita, Yasuo|Satoh, Toshimi|Tokunaga, Osamu | ||||||||||
| PMID: | 17096728 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Cancer. 2008 May 15;122(10):2266-73. | ||||||||||
| Title: | Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice. | ||||||||||
| Author: | Tsujie, Masanori|Tsujie, Tomoko|Toi, Hirofumi|Uneda, Shima|Shiozaki, Ken|Tsai, Hilda|Seon, Ben K | ||||||||||
| PMID: | 18224682 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Res. 2008 Sep 15;68(18):7293-303. | ||||||||||
| Title: | A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. | ||||||||||
| Author: | Clasper, Steven|Royston, Daniel|Baban, Dilair|Cao, Yihai|Ewers, Stephan|Butz, Stefan|Vestweber, Dietmar|Jackson, David G | ||||||||||
| PMID: | 18794116 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Cancer. 2009 Sep 15;125(6):1446-53. | ||||||||||
| Title: | Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature. | ||||||||||
| Author: | Uneda, Shima|Toi, Hirofumi|Tsujie, Tomoko|Tsujie, Masanori|Harada, Naoko|Tsai, Hilda|Seon, Ben K | ||||||||||
| PMID: | 19533687 | ||||||||||
| 13. | |||||||||||
| Journal: | Int J Oncol. 2010 Nov;37(5):1153-65. | ||||||||||
| Title: | Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. | ||||||||||
| Author: | Bellone, Graziella|Gramigni, Claudia|Vizio, Barbara|Mauri, Francesco A|Prati, Adriana|Solerio, Dino|Dughera, Luca|Ruffini, Enrico|Gasparri, Guido|Camandona, Michele | ||||||||||
| PMID: | 20878063 | ||||||||||
| 14. | |||||||||||
| Journal: | J Biol Chem. 2011 Aug 26;286(34):30034-46. | ||||||||||
| Title: | Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. | ||||||||||
| Author: | Castonguay, Roselyne|Werner, Eric D|Matthews, Robert G|Presman, Eleonora|Mulivor, Aaron W|Solban, Nicolas|Sako, Dianne|Pearsall, R Scott|Underwood, Kathryn W|Seehra, Jasbir|Kumar, Ravindra|Grinberg, Asya V | ||||||||||
| PMID: | 21737454 | ||||||||||
| 15. | |||||||||||
| Journal: | PLoS One. 2012;7(4):e34758. | ||||||||||
| Title: | Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection. | ||||||||||
| Author: | Dai, Jingyao|Wan, Shaogui|Zhou, Feng|Myers, Ronald E|Guo, Xu|Li, Bingshan|Fu, Xiaoying|Palazzo, Juan P|Dou, Kefeng|Yang, Hushan|Xing, Jinliang | ||||||||||
| PMID: | 22496856 | ||||||||||
| 16. | |||||||||||
| Journal: | Acta Medica (Hradec Kralove). 2012;55(2):74-7. | ||||||||||
| Title: | Preoperative serum levels of soluble endoglin for prediction of recurrence in stage III colorectal cancer patients. | ||||||||||
| Author: | Gomceli, Ismail|Tez, Mesut|Bostanci, Erdal B|Turhan, Nesrin|Kemik, Ahu S|Akoglu, Musa | ||||||||||
| PMID: | 23101269 | ||||||||||
| 17. | |||||||||||
| Journal: | J Proteome Res. 2013 Dec 6;12(12):5996-6003. | ||||||||||
| Title: | Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. | ||||||||||
| Author: | Lin, De|Alborn, William E|Slebos, Robbert J C|Liebler, Daniel C | ||||||||||
| PMID: | 24224610 | ||||||||||
| 18. | |||||||||||
| Journal: | BMC Cancer. 2014 Mar 13;14:178. | ||||||||||
| Title: | Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. | ||||||||||
| Author: | Bieche, Ivan|Vacher, Sophie|Vallerand, David|Richon, Sophie|Hatem, Rana|De Plater, Ludmilla|Dahmani, Ahmed|Nemati, Fariba|Angevin, Eric|Marangoni, Elisabetta|Roman-Roman, Sergio|Decaudin, Didier|Dangles-Marie, Virginie | ||||||||||
| PMID: | 24625025 | ||||||||||
| 19. | |||||||||||
| Journal: | Cancer Immunol Res. 2014 Nov;2(11):1090-102. | ||||||||||
| Title: | Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines. | ||||||||||
| Author: | Farsaci, Benedetto|Donahue, Renee N|Coplin, Michael A|Grenga, Italia|Lepone, Lauren M|Molinolo, Alfredo A|Hodge, James W | ||||||||||
| PMID: | 25092771 | ||||||||||
| 20. | |||||||||||
| Journal: | Int J Cancer. 2015 Jan 15;136(2):452-61. | ||||||||||
| Title: | Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105). | ||||||||||
| Author: | Toi, Hirofumi|Tsujie, Masanori|Haruta, Yuro|Fujita, Kanako|Duzen, Jill|Seon, Ben K | ||||||||||
| PMID: | 24866768 | ||||||||||
| 21. | |||||||||||
| Journal: | Gastroenterol Res Pract. 2015;2015:504179. | ||||||||||
| Title: | Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis. | ||||||||||
| Author: | Martinovic, Zeljko|Kovac, Drazen|Martinovic, Mia | ||||||||||
| PMID: | 26089870 | ||||||||||
| 22. | |||||||||||
| Journal: | World J Surg Oncol. 2016 Apr 22;14:122. | ||||||||||
| Title: | Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis. | ||||||||||
| Author: | Martinovic, Zeljko|Kovac, Drazen|Martinovic, Cvita | ||||||||||
| PMID: | 27102733 | ||||||||||
| 23. | |||||||||||
| Journal: | Anticancer Res. 2016 May;36(5):2271-80. | ||||||||||
| Title: | Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/beta-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer. | ||||||||||
| Author: | Mitselou, Antigony|Galani, Vassiliki|Skoufi, Urania|Arvanitis, Dimitris L|Lampri, Evangeli|Ioachim, Elli | ||||||||||
| PMID: | 27127133 | ||||||||||
| 24. | |||||||||||
| Journal: | Anticancer Res. 2016 Aug;36(8):3953-9. | ||||||||||
| Title: | Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer. | ||||||||||
| Author: | Ilhan, Nevin|Gungor, Hilal|Gul, H Fatih|Eroksuz, Hatice | ||||||||||
| PMID: | 27466499 | ||||||||||
| 25. | |||||||||||
| Journal: | Oncotarget. 2017 Jun 21;8(55):93450-93463. | ||||||||||
| Title: | Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort. | ||||||||||
| Author: | Raskin, Leon|Guo, Yan|Du, Liping|Clendenning, Mark|Rosty, Christophe|Lindor, Noralane M|Gruber, Stephen B|Buchanan, Daniel D | ||||||||||
| PMID: | 29212164 | ||||||||||